Delivery Order SPE2DB22D3401-SPE2DB22FT1XX
Award Date
9/15/22
Potential Completion Date
9/16/22
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mesalamine 800 mg delayed-release tablet prescription medication. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $7,927.03 and a completion date of April 22, 2024. This contract is not set aside and is a Firm Fixed Price Delivery Order. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $12,703.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of 4,565,805,308 units of Mesalamine 800 mg delayed-release tablets in 180-count bottles. This is a delivery order contract with a firm-fixed price, and the ultimate completion date is September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Mesalamine 800 mg delayed-release (DR) tablets. The $1,946.81 firm-fixed-price contract has an ultimate completion date of August 19, 2024 and does not utilize a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This federal contract award is for the delivery of Mesalamine 800 mg delayed-release tablets to the Defense Logistics Agency (DLA), a defense agency. The $2,026.42 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 29, 2024. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora,...
This federal contract award, valued at $7,326.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mesalamine delayed-release tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed-price delivery order. This award is not associated with any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,654.17 firm-fixed-price delivery order is for the supply of 180-count bottles of Mesalamine 800 mg delayed-release tablets. This contract item supports the medical needs of the U.S. Department of Defense and likely serves military treatment facilities and other government healthcare programs. The award is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Mesalamine 800 mg delayed-release tablets. The $13,126.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a period of performance through September 16, 2024 and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle the...
This federal contract award is for the delivery of Mesalamine 800 mg DR Tablets in quantities of 180 to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $4,517.65. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 12, 2024, with a period of performance through June 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,170.87, is for the delivery of 4,563,198,346 units of Mesalamine 800 mg delayed-release tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,978.92 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025 with...